Atlas Trials

Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

Clinical trial NCT05949801 · COMPLETED

Trial details

NCT number
NCT05949801
Sponsor
Zensun Sci. & Tech. Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Systolic Heart Failure
Start date
2023-04-13
Primary completion
2024-08-30
Enrollment
202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.